Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Combinatorial Chemistry & High Throughput Screening
  4. Fast Track Articles
  5. Fast Track Article
image of Ferroptosis-related Biotargets and Network Mechanisms of Maslinic Acid Against Myocardial Ischemia-reperfusion Injury: An Integrated Bioinformatic and Experimental Approach

Abstract

Background

Maslinic acid (MA), a pentacyclic triterpenoid compound derived from leaves and fruits of Olea europaea, bears multi-pharmacological properties. Our previous studies found that MA exerted a cardioprotective effect by modulating oxidative stress, inflammation, and apoptosis during myocardial ischemia-reperfusion injury (MIRI). Nevertheless, data regarding the anti-ferroptosis effects of MA on MI/RI remains unidentified.

Aim of the Study

This study aimed to explore the effects of MA on ferroptosis induced by MI/RI, with a focus on elucidating the underlying mechanisms through an integrated approach of network pharmacology and experimental validation.

Materials and Methods

Several public databases and a protein-protein interaction (PPI) network were used to identify the core targets shared by MI/RI, ferroptosis, and MA. The molecular function, cell component, biological process, and potential signaling pathways of core genes were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment. Subsequently, molecular docking and in vitro experiments were carried out to further validate network pharmacology results.

Results

A total of 21 unique intersection genes were obtained as potential targets of MA in treating MI/RI-induced ferroptosis. The 10 hub genes with the highest interaction scores were identified from PPI analysis. GO and KEGG enrichment showed the contribution of the core genes to pharmacological actions and mechanisms in MA treatment of MI/RI, especially the ferroptosis-related signaling pathways. Additionally, MA docked well with ranked core targets, including MAPK, MTOR, STAT3, PTGS2, and MDM2. Subsequently, in vitro experiments revealed that MA notably alleviated oxidative damage, reduced ferrous iron overload and ferroptosis, and regulated the expression of ferroptosis-related genes (GPX4, PTGS2, and ACSL4) in erastin-induced H9c2 cells. Meanwhile, MA could significantly reduce phosphorylation of MAPK (ERK1/2) levels in H9c2 cells.

Conclusion

By utilizing network pharmacology and experimental data, our study revealed the correlation between MA and ferroptosis following MI/RI, and concluded that MA might protect against MI/RI by reducing ferroptosis through the ERK1/2 signaling pathway. This finding offered fresh insights into the pharmacological mechanisms of MA against MI/RI.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073354768241217162514
2025-01-02
2025-03-01

  • From This Site

    /content/journals/cchts/10.2174/0113862073354768241217162514
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Martin S.S. Aday A.W. Almarzooq Z.I. Anderson C.A.M. Arora P. Avery C.L. Baker-Smith C.M. Barone Gibbs B. Beaton A.Z. Boehme A.K. Commodore-Mensah Y. Currie M.E. Elkind M.S.V. Evenson K.R. Generoso G. Heard D.G. Hiremath S. Johansen M.C. Kalani R. Kazi D.S. Ko D. Liu J. Magnani J.W. Michos E.D. Mussolino M.E. Navaneethan S.D. Parikh N.I. Perman S.M. Poudel R. Rezk-Hanna M. Roth G.A. Shah N.S. St-Onge M.P. Thacker E.L. Tsao C.W. Urbut S.M. Van Spall H.G.C. Voeks J.H. Wang N.Y. Wong N.D. Wong S.S. Yaffe K. Palaniappan L.P. 2024 heart disease and stroke statistics: A report of US and global data from the american heart association. Circulation 2024 149 8 e347 e913 10.1161/CIR.0000000000001209 38264914
    [Google Scholar]
  2. Welt F.G.P. Batchelor W. Spears J.R. Penna C. Pagliaro P. Ibanez B. Drakos S.G. Dangas G. Kapur N.K. Reperfusion injury in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 2024 83 22 2196 2213 10.1016/j.jacc.2024.02.056 38811097
    [Google Scholar]
  3. Hausenloy D.J. Yellon D.M. Myocardial ischemia-reperfusion injury: A neglected therapeutic target. J. Clin. Invest. 2013 123 1 92 100 10.1172/JCI62874 23281415
    [Google Scholar]
  4. Xing Y. Sui Z. Liu Y. Wang M. Wei X. Lu Q. Wang X. Liu N. Lu C. Chen R. Wu M. Wang Y. Zhao Y. Guo F. Cao J. Qi J. Wang W. Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy. Basic Res. Cardiol. 2022 117 1 20 10.1007/s00395‑022‑00930‑x 35389129
    [Google Scholar]
  5. Yin L. Li L. Gao M. Qi Y. Xu L. Peng J. circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis. Redox Biol. 2024 73 103175 103175 10.1016/j.redox.2024.103175 38795544
    [Google Scholar]
  6. Zhang S. Yan F. Luan F. Chai Y. Li N. Wang Y.W. Chen Z.L. Xu D.Q. Tang Y.P. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury. Phytomedicine 2024 129 155649 155649 10.1016/j.phymed.2024.155649 38653154
    [Google Scholar]
  7. Liu Y. Li L. Wang Z. Zhang J. Zhou Z. Myocardial ischemia-reperfusion injury; Molecular mechanisms and prevention. Microvasc. Res. 2023 149 104565 104565 10.1016/j.mvr.2023.104565 37307911
    [Google Scholar]
  8. Fang X. Ardehali H. Min J. Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat. Rev. Cardiol. 2023 20 1 7 23 10.1038/s41569‑022‑00735‑4 35788564
    [Google Scholar]
  9. Xiang Q. Yi X. Zhu X.H. Wei X. Jiang D.S. Regulated cell death in myocardial ischemia–reperfusion injury. Trends Endocrinol. Metab. 2024 35 3 219 234 10.1016/j.tem.2023.10.010 37981501
    [Google Scholar]
  10. Laukaitiene J. Gujyte G. Kadusevicius E. Cardiomyocyte damage: Ferroptosis relation to ischemia-reperfusion injury and future treatment options. Int. J. Mol. Sci. 2023 24 16 12846 10.3390/ijms241612846 37629039
    [Google Scholar]
  11. Dixon S.J. Lemberg K.M. Lamprecht M.R. Skouta R. Zaitsev E.M. Gleason C.E. Patel D.N. Bauer A.J. Cantley A.M. Yang W.S. Morrison B. III Stockwell B.R. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 2012 149 5 1060 1072 10.1016/j.cell.2012.03.042 22632970
    [Google Scholar]
  12. Li J. Cao F. Yin H. Huang Z. Lin Z. Mao N. Sun B. Wang G. Ferroptosis: Past, present and future. Cell Death Dis. 2020 11 2 88 10.1038/s41419‑020‑2298‑2 32015325
    [Google Scholar]
  13. Fang X. Wang H. Han D. Xie E. Yang X. Wei J. Gu S. Gao F. Zhu N. Yin X. Cheng Q. Zhang P. Dai W. Chen J. Yang F. Yang H.T. Linkermann A. Gu W. Min J. Wang F. Ferroptosis as a target for protection against cardiomyopathy. Proc. Natl. Acad. Sci. USA 2019 116 7 2672 2680 10.1073/pnas.1821022116 30692261
    [Google Scholar]
  14. Ishimaru K. Ikeda M. Miyamoto H.D. Furusawa S. Abe K. Watanabe M. Kanamura T. Fujita S. Nishimura R. Toyohara T. Matsushima S. Koumura T. Yamada K. Imai H. Tsutsui H. Ide T. Deferasirox targeting ferroptosis synergistically ameliorates myocardial ischemia reperfusion injury in conjunction with cyclosporine A. J. Am. Heart Assoc. 2024 13 1 e031219 10.1161/JAHA.123.031219 38158218
    [Google Scholar]
  15. Cai W. Liu L. Shi X. Liu Y. Wang J. Fang X. Chen Z. Ai D. Zhu Y. Zhang X. Alox15/15-HpETE aggravates myocardial ischemia-Reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation 2023 147 19 1444 1460 10.1161/CIRCULATIONAHA.122.060257 36987924
    [Google Scholar]
  16. Yan J. Li Z. Liang Y. Yang C. Ou W. Mo H. Tang M. Chen D. Zhong C. Que D. Feng L. Xiao H. Song X. Yang P. Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis via the NRF2 signaling pathway. Food Funct. 2023 14 22 10052 10068 10.1039/D3FO02633G 37861458
    [Google Scholar]
  17. Han X. Zhang J. Liu J. Wang H. Du F. Zeng X. Guo C. Targeting ferroptosis: A novel insight against myocardial infarction and ischemia–reperfusion injuries. Apoptosis 2023 28 1-2 108 123 10.1007/s10495‑022‑01785‑2 36474078
    [Google Scholar]
  18. Liu L. Pang J. Qin D. Li R. Zou D. Chi K. Wu W. Rui H. Yu H. Zhu W. Liu K. Wu X. Wang J. Xu P. Song X. Cao Y. Wang J. Xu F. Xue L. Chen Y. Deubiquitinase OTUD5 as a novel protector against 4‐HNE‐triggered ferroptosis in myocardial ischemia/reperfusion injury. Adv. Sci. (Weinh.) 2023 10 28 2301852 10.1002/advs.202301852 37552043
    [Google Scholar]
  19. Ichihara G. Katsumata Y. Sugiura Y. Matsuoka Y. Maeda R. Endo J. Anzai A. Shirakawa K. Moriyama H. Kitakata H. Hiraide T. Goto S. Ko S. Iwasawa Y. Sugai K. Daigo K. Goto S. Sato K. Yamada K. Suematsu M. Ieda M. Sano M. MRP1-dependent extracellular release of glutathione induces cardiomyocyte ferroptosis after ischemia-reperfusion. Circ. Res. 2023 133 10 861 876 10.1161/CIRCRESAHA.123.323517 37818671
    [Google Scholar]
  20. He Y. Wang Y. Yang K. Jiao J. Zhan H. Yang Y. Lv D. Li W. Ding W. Maslinic acid: A new compound for the treatment of multiple organ diseases. Molecules 2022 27 24 8732 10.3390/molecules27248732 36557864
    [Google Scholar]
  21. Yan R. Liu L. Huang X. Quan Z.S. Shen Q.K. Guo H.Y. Bioactivities and structure‐activity relationships of maslinic acid derivatives: A review. Chem. Biodivers. 2024 21 2 e202301327 10.1002/cbdv.202301327 38108648
    [Google Scholar]
  22. Ooi K.X. Poo C.L. Subramaniam M. Cordell G.A. Lim Y.M. Maslinic acid exerts anticancer effects by targeting cancer hallmarks. Phytomedicine 2023 110 154631 154631 10.1016/j.phymed.2022.154631 36621168
    [Google Scholar]
  23. Fang M. Deng J. Zhou Q. Hu Z. Yang L. Maslinic acid protects against pressure-overload-induced cardiac hypertrophy by blocking METTL3-mediated m6A methylation. Aging 2022 14 6 2548 2557 10.18632/aging.203860 35347085
    [Google Scholar]
  24. Li L. Lin L. Lei S. Shi S. Chen C. Xia Z. Maslinic acid inhibits myocardial ischemia–reperfusion injury-induced apoptosis and necroptosis via promoting autophagic flux. DNA Cell Biol. 2022 41 5 487 497 10.1089/dna.2021.0918 35475713
    [Google Scholar]
  25. Wang N. Ma Z. Chen C. Xiao N. Effects of maslinic acid on cardiac function in ischemia-reperfusion injury rats. J. Investig. Med. 2022 70 1 20 28 10.1136/jim‑2021‑001927 34193533
    [Google Scholar]
  26. Li Q. Xu M. Li Z. Li T. Wang Y. Chen Q. Wang Y. Feng J. Yin X. Lu C. Maslinic acid attenuates ischemia/reperfusion injury-induced myocardial inflammation and apoptosis by regulating HMGB1-TLR4 axis. Front. Cardiovasc. Med. 2021 8 768947 768947 10.3389/fcvm.2021.768947 34859077
    [Google Scholar]
  27. Li Q. Li Z. Liu C. Xu M. Li T. Wang Y. Feng J. Yin X. Du X. Lu C. Maslinic acid ameliorates myocardial ischemia reperfusion injury-induced oxidative stress via activating Nrf2 and inhibiting NF-κB pathways. Am. J. Chin. Med. 2023 51 4 929 951 10.1142/S0192415X2350043X 36974993
    [Google Scholar]
  28. Nogales C. Mamdouh Z.M. List M. Kiel C. Casas A.I. Schmidt H.H.H.W. Network pharmacology: Curing causal mechanisms instead of treating symptoms. Trends Pharmacol. Sci. 2022 43 2 136 150 10.1016/j.tips.2021.11.004 34895945
    [Google Scholar]
  29. Ru J. Li P. Wang J. Zhou W. Li B. Huang C. Li P. Guo Z. Tao W. Yang Y. Xu X. Li Y. Wang Y. Yang L. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform. 2014 6 1 13 10.1186/1758‑2946‑6‑13 24735618
    [Google Scholar]
  30. Daina A. Michielin O. Zoete V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019 47 W1 W357 W364 10.1093/nar/gkz382 31106366
    [Google Scholar]
  31. Gallo K. Goede A. Preissner R. Gohlke B.O. SuperPred 3.0: Drug classification and target prediction—A machine learning approach. Nucleic Acids Res. 2022 50 W1 W726 W731 10.1093/nar/gkac297 35524552
    [Google Scholar]
  32. Wishart D.S. Feunang Y.D. Guo A.C. Lo E.J. Marcu A. Grant J.R. Sajed T. Johnson D. Li C. Sayeeda Z. Assempour N. Iynkkaran I. Liu Y. Maciejewski A. Gale N. Wilson A. Chin L. Cummings R. Le D. Pon A. Knox C. Wilson M. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 46 D1 D1074 D1082 10.1093/nar/gkx1037 29126136
    [Google Scholar]
  33. Szklarczyk D. Gable A.L. Nastou K.C. Lyon D. Kirsch R. Pyysalo S. Doncheva N.T. Legeay M. Fang T. Bork P. Jensen L.J. von Mering C. The STRING database in 2021: Customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021 49 D1 D605 D612 10.1093/nar/gkaa1074 33237311
    [Google Scholar]
  34. Doncheva N.T. Morris J.H. Gorodkin J. Jensen L.J. Cytoscape StringApp: Network analysis and visualization of proteomics data. J. Proteome Res. 2019 18 2 623 632 10.1021/acs.jproteome.8b00702 30450911
    [Google Scholar]
  35. Yin Z. Ding G. Chen X. Qin X. Xu H. Zeng B. Ren J. Zheng Q. Wang S. Beclin1 haploinsufficiency rescues low ambient temperature-induced cardiac remodeling and contractile dysfunction through inhibition of ferroptosis and mitochondrial injury. Metabolism 2020 113 154397 154397 10.1016/j.metabol.2020.154397 33058849
    [Google Scholar]
  36. Zhu Z. Liu Y. Gong Y. Jin W. Topchiy E. Turdi S. Gao Y. Culver B. Wang S. Ge W. Zha W. Ren J. Pei Z. Qin X. Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of alzheimer’s disease via inhibition of ACSL4-dependent ferroptosis. Acta Pharmacol. Sin. 2022 43 1 39 49 10.1038/s41401‑021‑00635‑2 33767380
    [Google Scholar]
  37. Dong L. Shen Z. Chi H. Wang Y. Shi Z. Fang H. Yang Y. Rong J. Research progress of chinese medicine in the treatment of myocardial ischemia–Reperfusion injury. Am. J. Chin. Med. 2023 51 1 1 17 10.1142/S0192415X23500015 36437553
    [Google Scholar]
  38. Wang K. Li Y. Qiang T. Chen J. Wang X. Role of epigenetic regulation in myocardial ischemia/reperfusion injury. Pharmacol. Res. 2021 170 105743 105743 10.1016/j.phrs.2021.105743 34182132
    [Google Scholar]
  39. Li Q. Li Z. Fan Z. Yang Y. Lu C. Involvement of non‑coding RNAs in the pathogenesis of myocardial ischemia/reperfusion injury (Review). Int. J. Mol. Med. 2021 47 4 42 10.3892/ijmm.2021.4875 33576444
    [Google Scholar]
  40. Ooi B.K. Phang S.W. Yong P.V.C. Chellappan D.K. Dua K. Khaw K.Y. Goh B.H. Pusparajah P. Yap W.H. In vitro evaluation of the involvement of Nrf2 in maslinic acid-mediated anti-inflammatory effects in atheroma pathogenesis. Life Sci. 2021 278 119658 119658 10.1016/j.lfs.2021.119658 34048809
    [Google Scholar]
  41. Jing Z. Rui W. Ruihua L. Hao Y. Hengtong F. Review of the biological activity of maslinic acid. Curr. Drug Targets 2021 22 13 1496 1506 10.2174/1389450122666210308111159 33687879
    [Google Scholar]
  42. Liu Y.L. Kong C.Y. Song P. Zhou H. Zhao X.S. Tang Q.Z. Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice. J. Pharmacol. Sci. 2018 138 2 116 122 10.1016/j.jphs.2018.08.014 30389277
    [Google Scholar]
  43. Chen W. Zhang Y. Wang Z. Tan M. Lin J. Qian X. Li H. Jiang T. Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition. Front. Pharmacol. 2023 14 1078205 1078205 10.3389/fphar.2023.1078205 36891270
    [Google Scholar]
  44. Xiao Y. Ding L. Mechanistic study of electroacupuncture preconditioning in alleviating myocardial ischemia-reperfusion injury in rats: Involvement of mTOR/ROS signaling pathway to inhibit ferroptosis. Int. J. Neurosci. 2024 1 9 10.1080/00207454.2023.2299315 38197187
    [Google Scholar]
  45. Xu X. Mao C. Zhang C. Zhang M. Gong J. Wang X. Salvianolic acid B inhibits ferroptosis and apoptosis during myocardial ischemia/reperfusion injury via decreasing the ubiquitin-proteasome degradation of GPX4 and the ROS-JNK/MAPK pathways. Molecules 2023 28 10 4117 10.3390/molecules28104117 37241859
    [Google Scholar]
  46. Jin Y. Tan M. Yin Y. Lin C. Zhao Y. Zhang J. Jiang T. Li H. He M. Oroxylin A alleviates myocardial ischemia–reperfusion injury by quelling ferroptosis via activating the DUSP10/MAPK ‐Nrf2 pathway. Phytother. Res. 2024 38 11 5290 5308 10.1002/ptr.8315 39225191
    [Google Scholar]
  47. Liu C. Li Z. Li B. Liu W. Zhang S. Qiu K. Zhu W. Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: A mini-review. PeerJ 2023 11 e14952 10.7717/peerj.14952
    [Google Scholar]
  48. Jiang X. Stockwell B.R. Conrad M. Ferroptosis: Mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 2021 22 4 266 282 10.1038/s41580‑020‑00324‑8 33495651
    [Google Scholar]
  49. Chen X. Li J. Kang R. Klionsky D.J. Tang D. Ferroptosis: Machinery and regulation. Autophagy 2021 17 9 2054 2081 10.1080/15548627.2020.1810918 32804006
    [Google Scholar]
  50. Pope L.E. Dixon S.J. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023 33 12 1077 1087 10.1016/j.tcb.2023.05.003 37407304
    [Google Scholar]
  51. Wang Z. Yao M. Jiang L. Wang L. Yang Y. Wang Q. Qian X. Zhao Y. Qian J. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis. Biomed. Pharmacother. 2022 154 113572 113572 10.1016/j.biopha.2022.113572 35988428
    [Google Scholar]
  52. Ju J. Li X.M. Zhao X.M. Li F.H. Wang S.C. Wang K. Li R.F. Zhou L.Y. Liang L. Wang Y. Zhang Y.H. Wang K. Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia/reperfusion injury by interacting with NAMPT. J. Biomed. Sci. 2023 30 1 45 10.1186/s12929‑023‑00927‑1 37370086
    [Google Scholar]
  53. Fan Z. Cai L. Wang S. Wang J. Chen B. Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting acsl4 mediated ferroptosis. Front. Pharmacol. 2021 12 628988 628988 10.3389/fphar.2021.628988 33935719
    [Google Scholar]
  54. Li T. Tan Y. Ouyang S. He J. Liu L. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene 2022 808 145968 145968 10.1016/j.gene.2021.145968 34530090
    [Google Scholar]
  55. Han Y. Yuan H. Li F. Yuan Y. Zheng X. Zhang X. Sun J. Ammidin ameliorates myocardial hypoxia/reoxygenation injury by inhibiting the ACSL4/AMPK/mTOR-mediated ferroptosis pathway. BMC Complement. Med. Ther. 2023 23 1 459 10.1186/s12906‑023‑04289‑x 38102654
    [Google Scholar]
  56. Tu H. Zhou Y.J. Tang L.J. Xiong X.M. Zhang X.J. Ali Sheikh M.S. Zhang J.J. Luo X.J. Yuan C. Peng J. Combination of ponatinib with deferoxamine synergistically mitigates ischemic heart injury via simultaneous prevention of necroptosis and ferroptosis. Eur. J. Pharmacol. 2021 898 173999 173999 10.1016/j.ejphar.2021.173999 33675785
    [Google Scholar]
  57. Li W. Li W. Wang Y. Leng Y. Xia Z. Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated ferritinophagy during diabetes myocardial ischemia/reperfusion injury. Cell Death Discov. 2021 7 1 267 10.1038/s41420‑021‑00656‑0 34588431
    [Google Scholar]
  58. Ge C. Peng Y. Li J. Wang L. Zhu X. Wang N. Yang D. Zhou X. Chang D. Hydroxysafflor yellow a alleviates acute myocardial ischemia/reperfusion injury in mice by inhibiting ferroptosis via the activation of the HIF-1α/SLC7A11/GPX4 signaling pathway. Nutrients 2023 15 15 3411 10.3390/nu15153411 37571350
    [Google Scholar]
  59. Yao D. Bao L. Wang S. Tan M. Xu Y. Wu T. Zhang Z. Gong K. Isoliquiritigenin alleviates myocardial ischemia-reperfusion injury by regulating the Nrf2/HO-1/SLC7a11/GPX4 axis in mice. Free Radic. Biol. Med. 2024 221 1 12 10.1016/j.freeradbiomed.2024.05.012
    [Google Scholar]
  60. Chen Y. Li X. Wang S. Miao R. Zhong J. Targeting iron metabolism and ferroptosis as novel therapeutic approaches in cardiovascular diseases. Nutrients 2023 15 3 591 10.3390/nu15030591 36771298
    [Google Scholar]
  61. Qiu M.L. Yan W. Liu M.M. Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4 ‐mediated ferroptosis. Kaohsiung J. Med. Sci. 2023 39 10 989 1001 10.1002/kjm2.12733 37530646
    [Google Scholar]
  62. Rose B.A. Force T. Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 2010 90 4 1507 1546 10.1152/physrev.00054.2009 20959622
    [Google Scholar]
  63. Hõrak H. Defense, fast and slow: Activation of different MAPK pathways in response to wounding. Plant Cell 2020 32 6 1788 1789 10.1105/tpc.20.00282 32284346
    [Google Scholar]
  64. Haakenson J. Wu J.Y. Xiang S. Williams K.A. Bai W. Zhang X. HDAC6-dependent functions in tumor cells: Crossroad with the MAPK pathways. Crit. Rev. Oncog. 2015 20 1-2 65 81 10.1615/CritRevOncog.2014012484 25746105
    [Google Scholar]
  65. Espinosa-Gil S. Ivanova S. Alari-Pahissa E. Denizli M. Villafranca-Magdalena B. Viñas-Casas M. Bolinaga-Ayala I. Gámez-García A. Faundez-Vidiella C. Colas E. Lopez-Botet M. Zorzano A. Lizcano J.M. MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists. Cell Death Dis. 2023 14 11 715 10.1038/s41419‑023‑06229‑6 37919293
    [Google Scholar]
  66. Li Y. Zhou Y. Liu D. Wang Z. Qiu J. Zhang J. Chen P. Zeng G. Guo Y. Wang X. DiSanto M.E. Zhang X. Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK/ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate. J. Transl. Med. 2023 21 1 575 10.1186/s12967‑023‑04432‑9 37633909
    [Google Scholar]
  67. Savic D. Steinbichler T.B. Ingruber J. Negro G. Aschenbrenner B. Riechelmann H. Ganswindt U. Skvortsov S. Dudás J. Skvortsova I.I. Erk1/2-dependent HNSCC cell susceptibility to erastin-induced ferroptosis. Cells 2023 12 2 336 10.3390/cells12020336 36672272
    [Google Scholar]
  68. Popov S.V. Maslov L.N. Mukhomedzyanov A.V. Kurbatov B.K. Gorbunov A.S. Kilin M. Azev V.N. Khlestkina M.S. Sufianova G.Z. Apelin is a prototype of novel drugs for the treatment of acute myocardial infarction and adverse myocardial remodeling. Pharmaceutics 2023 15 3 1029 10.3390/pharmaceutics15031029 36986889
    [Google Scholar]
  69. Wan F. He X. Xie W. Canagliflozin inhibits palmitic acid-induced vascular cell aging in vitro through ROS/ERK and ferroptosis pathways. Antioxidants 2024 13 7 831 10.3390/antiox13070831 39061899
    [Google Scholar]
  70. Ryabov V.V. Maslov L.N. Vyshlov E.V. Mukhomedzyanov A.V. Kilin M. Gusakova S.V. Gombozhapova A.E. Panteleev O.O. Ferroptosis, a regulated form of cell death, as a target for the development of novel drugs preventing ischemia/reperfusion of cardiac injury, cardiomyopathy and stress-induced cardiac injury. Int. J. Mol. Sci. 2024 25 2 897 10.3390/ijms25020897 38255971
    [Google Scholar]
  71. Yang Y.Y. Deng R.R. Xiang D.X. Naodesheng pills ameliorate cerebral ischemia reperfusion-induced ferroptosis via inhibition of the ERK1/2 signaling pathway. Drug Des. Devel. Ther. 2024 18 1499 1514 10.2147/DDDT.S443479 38716368
    [Google Scholar]
  72. Kim N.Y. Shivanne Gowda S.G. Lee S.G. Sethi G. Ahn K.S. Cannabidiol induces ERK activation and ROS production to promote autophagy and ferroptosis in glioblastoma cells. Chem. Biol. Interact. 2024 394 110995 110995 10.1016/j.cbi.2024.110995 38583854
    [Google Scholar]
  73. Sun W. Choi H.S. Kim C.S. Bae E.H. Ma S.K. Kim S.W. Maslinic acid attenuates ischemia/reperfusion-induced acute kidney injury by suppressing inflammation and apoptosis through inhibiting NF-κB and MAPK signaling pathway. Front. Pharmacol. 2022 13 807452 10.3389/fphar.2022.807452 35496304
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073354768241217162514
Loading
Ferroptosis-related Biotargets and Network Mechanisms of Maslinic Acid Against Myocardial Ischemia-reperfusion Injury: An Integrated Bioinformatic and Experimental Approach
Bentham Science Publishers ; https://doi.org/10.2174/0113862073354768241217162514
/content/journals/cchts/10.2174/0113862073354768241217162514
/content/journals/cchts/10.2174/0113862073354768241217162514
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Maslinic acid ; network pharmacology ; myocardial ischemia-reperfusion injury ; ferroptosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test